Loading provider…
Loading provider…
Hematology & Oncology Physician in Shreveport, LA
NPI: 1013108141Primary Practice Location
CHRISTUS ST FRANCES CABRINI HOSPITAL
3330 Masonic Dr, Alexandria, LA
Primary Employer
Christus Trinity Clinic
christushealth.org
HQ Phone
Get M.D. Neelima's Phone Numberphone_androidMobile
Get M.D. Neelima's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardLA State Medical License
University of the West Indies Faculty of Medicine
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 286 | 772 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 96 | 115 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 92 | 203 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 45 | 89 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 36 | 36 |
A Gut Reaction
Authors: Glenn Mills, Xin Gu
Publication Date: 2007-02
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Fulvestrant, DRUG: Alpelisib
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: placebo, DRUG: tamoxifen citrate, DRUG: everolimus, DRUG: anastrozole, DRUG: exemestane, DRUG: letrozole, DRUG: goserelin acetate, DRUG: leuprolide acetate
Lead Sponsor: NovoCure GmbH
Intervention / Treatment: DEVICE: NovoTTF-200T, DRUG: Immune checkpoint inhibitors or docetaxel